C.R.S. § 25.5-5-519: Pharmacy reimbursement - parenteral nutrition - report - definitions.

(1) As used in this section, unless the context otherwise requires:

(a) "Infusion pharmacy" means a prescription drug outlet that prepares and dispenses a solution that includes parenteral nutrition for direct administration into a patient's bloodstream. The solution may contain medications or other treatments and may be administered in a patient's home or in a health-care facility.

(b) "Parenteral nutrition" means a form of nutritional support that provides a patient with needed nutrients, including, at a minimum, carbohydrates, amino acids, and lipids, through an intravenous infusion.

(2) (a) Upon receiving any necessary federal approval pursuant to subsection (2)(c) of this section, beginning on or before January 1, 2026, the state department shall create specific professional dispensing fees for the preparation and dispensing of parenteral nutrition to encourage an adequate level of market participation among infusion pharmacies.

(b) During the year beginning January 1, 2026, the specific professional dispensing fees must not exceed thirty percent of infusion pharmacy administrative costs for the preparation and dispensing of parenteral nutrition.

(c) The state department shall seek federal authorization, as necessary, to implement the professional dispensing fees pursuant to this subsection (2).

(3) Notwithstanding section 24-1-136 (11)(a)(I), on or before November 1, 2026, and on or before every November 1 thereafter, the state department shall, within existing appropriations, report in its presentation to the joint budget committee and its "SMART Act" hearing held pursuant to section 2-7-203 on:

(a) The total number and geographic distribution of infusion pharmacies throughout Colorado that provide parenteral nutrition to members;

(b) The number of new infusion pharmacies participating in the medical assistance program;

(c) Separate data on the parenteral nutrition needs of adult and child members and the sufficiency of the infusion pharmacy network to serve each; and

(d) Any regulatory or reimbursement changes the state department has undertaken to encourage an adequate level of market participation among infusion pharmacies to meet the parenteral nutrition needs of members.